1CP
WST icon

1015 Capital Partners’s West Pharmaceutical WST Stock Holding History

1015 Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718 Hold
2
– – ﹤0.01% 509
2026
Q1 		$501 Hold
2
– – ﹤0.01% 530
2025
Q4 		$550 Buy
+2
New +$547 ﹤0.01% 543

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

1015 Capital Partners's WST Position: Q2 2026 in Review

1015 Capital Partners held its West Pharmaceutical (WST) position steady in Q2 2026 at 2 shares worth $718. The position accounts for ﹤0.01% of the portfolio, ranked #509.

1015 Capital Partners first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 826 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • 1015 Capital Partners held 2 shares of West Pharmaceutical worth $718 as of Q2 2026.
  • 1015 Capital Partners left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of 1015 Capital Partners's portfolio in Q2 2026, its #509 holding.
  • 1015 Capital Partners first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 826 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.